Seeking partners for HORIZON-CL4-2026-04-DIGITAL-EMERGING-19: Challenge-Driven GenAI4EU Booster

We are forming a consortium to respond to the Horizon Europe Research and Innovation Action (RIA) GenAI4EU Booster in the pharmaceutical sector. Our goal is to transform real-world drug discovery bottlenecks with a focus on Neurodegenerative Diseases into high-impact "Challenges" to be solved. By acting as a neutral orchestrator, we will enable pharmaceutical companies and drug developers to safely engage with the European GenAI startup ecosystem to accelerate their R&D pipelines.

What We Offer:

• Proven "Challenge" Framework: We provide the administrative engine to manage the full lifecycle of the program, including vetting, high-quality judging panels, and the distribution of Financial Support to Third Parties (FSTP).

• Consortium Management: Deep experience in leading multi-stakeholder programs, including governance, compliance, and reporting for large-scale innovation actions.

• Neutral Innovation Brokerage: We act as a firewall between industry and AI developers, ensuring IP and data security while maximizing the quality of the generated AI solutions.

Partner Search:

We are urgently seeking pharmaceutical / drug development industry partners to help define the real-world R&D bottlenecks that the program will work to solve. Partners can engage flexibly, including:

• Defining Use Cases: Shaping the technical challenges included in the proposal.

• Data Provision: Contributing datasets (e.g., clinical records, imaging, omics data) or platform services for model fine-tuning.

• Expert Mentorship: Providing in-kind support through technical expertise or infrastructure for participants.

• Ecosystem Visibility: Supporting outreach to attract top-tier AI developers and SMEs to the challenge.

Contact us if you are interested in being involved or want to discuss!